Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morris

Showing results (151-160 of 185) with videos related to

Pageof 19
Sort By:
Lancet (London, England)|January 29, 2002
Counting alleles to predict recurrence of early-stage colorectal cancersWei Zhou, Steven N Goodman, Gennaro Galizia, et al.
Journal of Medicinal Chemistry|May 16, 2003
Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitorsGuoxin Zhu, Scott E Conner, Xun Zhou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 28, 2026
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's DiseaseSimon Rowe, Amy Evans, Saeed Kayhanian, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Regulation of RNA methylation by therapy treatment, promotes tumor survivalSyed Ia Bukhari, Samuel S Truesdell, Chandreyee Datta, et al.
Cell Reports|February 23, 2023
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent stateSatoru Matsuda, Ajinkya Revandkar, Taronish D Dubash, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Cancer Research|January 21, 2006
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arraysMadhumita Chatterjee, Saroj Mohapatra, Alexei Ionan, et al.
Clinical and Translational Radiation Oncology|June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysisAmit Roy, Randall J Brenneman, Jacob Hogan, et al.
Nature Communications|January 24, 2026
Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regenerationNikolaos Tsopoulidis, Masaki Yagi, Justin Brumbaugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2025
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitorsElad Horwitz, Taronish D Dubash, Annamaria Szabolcs, et al.
Pageof 19

Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Lancet (London, England)|January 29, 2002
Counting alleles to predict recurrence of early-stage colorectal cancersWei Zhou, Steven N Goodman, Gennaro Galizia, et al.
Journal of Medicinal Chemistry|May 16, 2003
Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitorsGuoxin Zhu, Scott E Conner, Xun Zhou, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 28, 2026
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's DiseaseSimon Rowe, Amy Evans, Saeed Kayhanian, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2023
Regulation of RNA methylation by therapy treatment, promotes tumor survivalSyed Ia Bukhari, Samuel S Truesdell, Chandreyee Datta, et al.
Cell Reports|February 23, 2023
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent stateSatoru Matsuda, Ajinkya Revandkar, Taronish D Dubash, et al.
Cell Chemical Biology|November 21, 2023
Genetic retargeting of E3 ligases to enhance CAR T cell therapyIsabel C Lane, Gabriele Kembuan, Jeannie Carreiro, et al.
Cancer Research|January 21, 2006
Diagnostic markers of ovarian cancer by high-throughput antigen cloning and detection on arraysMadhumita Chatterjee, Saroj Mohapatra, Alexei Ionan, et al.
Clinical and Translational Radiation Oncology|June 17, 2021
Does the sequence of high-dose rate brachytherapy boost and IMRT for prostate cancer impact early toxicity outcomes? Results from a single institution analysisAmit Roy, Randall J Brenneman, Jacob Hogan, et al.
Nature Communications|January 24, 2026
Modulation of Nudt21 levels reveals dose-dependent roles of alternative polyadenylation in tissue regenerationNikolaos Tsopoulidis, Masaki Yagi, Justin Brumbaugh, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 7, 2025
CDKN1B (p27/kip1) enhances drug-tolerant persister CTCs by restricting polyploidy following mitotic inhibitorsElad Horwitz, Taronish D Dubash, Annamaria Szabolcs, et al.
Pageof 19